Do elevated ApoB, LDL particle number, and lipoprotein(a) increase vessel-wall atherogenic contact?

Elevated circulating levels of apolipoprotein B (apoB)-containing lipoproteins, low-density lipoprotein particles (LDL-P), and lipoprotein(a) [Lp(a)] initiate atherogenesis through a concentration-dependent process of vascular infiltration, retention, and localized signaling.

Vascular infiltration and retention

• Transcytosis and trapping: Circulating particles ≤70 nm cross the endothelium via active transcytosis mediated by scavenger receptor-BI (SR-BI) and ALK1 receptors.
• Subendothelial anchoring: Positively charged residues on the apoB-100 backbone bind electrostatically to intimal proteoglycans (such as biglycan and versican). Lp(a) further binds to extracellular fibronectin via its lysine-binding kringle domains, compounding subendothelial particle retention.

Endothelial inflammation

• Receptor activation: Retained particles undergo oxidation into oxidized LDL (oxLDL), which binds scavenger receptors (primarily LOX-1) and Toll-like receptors (TLR4, TLR2/6) on endothelial cells.
• Inflammatory cascade: This binding activates the NF-κB pathway, triggering the transcription of adhesion molecules (VCAM-1, ICAM-1), chemokines (MCP-1), and inflammatory cytokines (IL-1β, TNF-α) that drive localized vascular dysfunction.

Platelet activation pathways

• Direct CD36 signaling: oxLDL and oxidized phospholipids bind directly to the platelet scavenger receptor CD36, initiating an intracellular signaling cascade involving Src family kinases (Fyn, Lyn), Syk, and PLCγ2.
• Thrombotic priming: This cascade drives intracellular calcium release, generates reactive oxygen species via NOX2, reduces platelet sensitivity to nitric oxide, and activates integrin αIIbβ3 and P-selectin, rendering platelets hyperreactive.
• Endothelial recruitment: The dysfunctional, inflamed endothelium recruits these primed platelets to the vessel wall by upregulating surface adhesion molecules and secreting von Willebrand factor.

Bottom line

• Elevated ApoB, LDL-P, and Lp(a) drive a concentration-dependent cascade where subendothelial particle accumulation and oxidation trigger LOX-1/NF-κB-mediated endothelial inflammation and CD36-mediated platelet activation, directly accelerating atherothrombotic progression.